查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654161

急性復發性癲癇市場規模、佔有率、趨勢分析報告：產品、地區、細分市場預測，2025-2030 年

Acute Repetitive Seizures Market Size, Share & Trends Analysis Report By Product (USL-261, NRL-1, AZ-002, Diastat Rectal Gel), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

急性復發性癲癇市場的成長與趨勢

根據 Grand View Research, Inc. 的最新報告，全球急性復發性癲癇市場規模預計到 2030 年將達到 64.8 億美元，2025 年至 2030 年的複合年成長率為 12.7%。

不斷提高人們對癲癇的認知是推動市場發展的主要因素。

目前市場由學名藥驅動，主要含有口服苯二氮平類藥物（Diazepam和Lorazepam）。唯一核准使用的藥物是美國的直腸地西Diazepam和歐盟的頰部咪達唑侖。其他藥物，如Diazepam（口服和肌肉注射）、咪達唑侖（頰內、鼻內、肌肉注射）、Lorazepam（口服、鼻內、舌下）和黃體酮，主要用於仿單標示外。市場由少數幾家大公司主導，預計這些公司將佔據較高的市場佔有率。

此外，為了控制醫療支出，政府正在努力透過診所和居家醫療等門診護理模式來減少住院時間和現場護理費用。印度和中國等新興經濟體正在擴大實施此類醫療改革，預計將推動急性復發性癲癇市場的成長。

給藥途徑有多種，其中鼻腔途徑比頰部、直腸和非腸道途徑更受青睞。口腔給藥較受兒童癲癇病患兒的看護者和家長的青睞，因為這種方式可以在醫院外給藥。

急性復發性癲癇市場報告重點

  • 預計 2024 年全球急性複發性癲癇市場規模為 31.5 億美元，預測期內複合年成長率為 12.7%。
  • USL-261 佔據市場主導地位，到 2024 年將佔 44.5% 的佔有率。這是因為它作為一種鼻內治療手段能夠快速控制癲癇發作。
  • 北美急性復發性癲癇市場佔據全球市場主導地位，2024 年的收入佔有率為 43.0%。該地區市場的成長得益於癲癇和神經系統疾病的高發性，以及強大的醫療保健基礎設施。
  • 2024 年，日本急性反覆癲癇市場在亞太地區急性反覆癲癇市場佔據主導地位。人口老化和對神經系統疾病認知的提高刺激了對有效治療方法的需求。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章急性複發性癲癇市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析 – 波特五力分析
    • PESTLE分析

第 4 章急性複發性癲癇市場：產品業務分析

  • 2024 年及 2030 年產品市場佔有率
  • 產品細分儀表板
  • 2018 年至 2030 年按產品分類的市場規模、預測與趨勢分析
  • USL-261
  • NRL-1
  • AZ-002
  • Diastat 直腸凝膠
  • 其他

第 5 章急性複發性癲癇市場：區域、估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 市場規模、預測趨勢分析，2018-2030
  • 北美洲
    • 依國家/地區，2018 年至 2030 年
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 依國家/地區，2018 年至 2030 年
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 依國家/地區，2018 年至 2030 年
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 依國家/地區，2018 年至 2030 年
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 依國家/地區，2018 年至 2030 年
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭格局

  • 參與者概述
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • UCB SA, Belgium
    • Neurelis, Inc.
    • Bausch Health Companies Inc.
    • Grupo Ferrer Internacional, SA
    • SERB
Product Code: GVR-2-68038-489-5

Acute Repetitive Seizures Market Growth & Trends:

The global acute repetitive seizures market size is estimated to reach USD 6.48 billion by 2030, expanding at a CAGR of 12.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rise in the number of initiatives to increase awareness about epilepsy is the major factor driving the market.

The market is currently led by generic drugs which mainly include oral benzodiazepines (diazepam and lorazepam). Rectal diazepam is the only approved drug for use in U.S. and buccal midazolam in the European Union. Other drugs, such as diazepam (oral and intramuscular), midazolam (buccal, intranasal, intramuscular), lorazepam (oral, intranasal, sublingual), and progesterone are majorly used off label. The market is expected to be consolidated with a few major companies and a high market share.

Furthermore, in an attempt to curb healthcare expenditure, governments are making continuous efforts to reduce hospital stays and on-site treatment costs via outpatient care models, such as clinic and home healthcare. Emerging economies like India and China, are increasingly implementing such healthcare reform, which is expected to propel the growth of acute repetitive seizures market.

There are several routes of drug administration; out of which, the nasal route is the most preferred over others, such as buccal, rectal, and parenteral. The buccal route is preferred by caregivers and parents for children suffering from pediatric seizures since medication can be administered even outside the hospital.

Acute Repetitive Seizures Market Report Highlights:

  • Global acute repetitive seizures market size was estimated at USD 3.15 billion in 2024 and is expected to register a CAGR of 12.7% over the forecast period
  • USL-261 dominated the market and accounted for a share of 44.5% in 2024, owing to its effectiveness as an intranasal treatment aimed at achieving rapid seizure control.
  • North America acute repetitive seizures market dominated the global market with a revenue share of 43.0% in 2024. Market growth in the region is driven by a high prevalence of epilepsy and neurological disorders, complemented by a robust healthcare infrastructure.
  • The acute repetitive seizures market in Japan dominated the Asia Pacific acute repetitive seizures market in 2024. The aging population, coupled with rising awareness of neurological disorders, stimulates demand for effective therapies.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Acute Repetitive Seizures Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Acute Repetitive Seizures Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. USL-261
    • 4.4.1. USL-261 Market, 2018 - 2030 (USD Million)
  • 4.5. NRL-1
    • 4.5.1. NRL-1 Market, 2018 - 2030 (USD Million)
  • 4.6. AZ-002
    • 4.6.1. AZ-002 Market, 2018 - 2030 (USD Million)
  • 4.7. Diastat Rectal Gel
    • 4.7.1. Diastat Rectal Gel Market, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Acute Repetitive Seizures Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Share Analysis, 2024 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.4. North America
    • 5.4.1. North America Acute Repetitive Seizures Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 5.4.2. U.S.
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Regulatory Framework
      • 5.4.2.3. Competitive Insights
      • 5.4.2.4. U.S. Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Canada
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Regulatory Framework
      • 5.4.3.3. Competitive Insights
      • 5.4.3.4. Canada Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Mexico
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Regulatory Framework
      • 5.4.4.3. Competitive Insights
      • 5.4.4.4. Mexico Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Europe
    • 5.5.1. Europe Acute Repetitive Seizures Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 5.5.2. UK
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Regulatory Framework
      • 5.5.2.3. Competitive Insights
      • 5.5.2.4. UK Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Germany
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Regulatory Framework
      • 5.5.3.3. Competitive Insights
      • 5.5.3.4. Germany Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. France
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Regulatory Framework
      • 5.5.4.3. Competitive Insights
      • 5.5.4.4. France Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.5.5. Italy
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Regulatory Framework
      • 5.5.5.3. Competitive Insights
      • 5.5.5.4. Italy Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.5.6. Spain
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Regulatory Framework
      • 5.5.6.3. Competitive Insights
      • 5.5.6.4. Spain Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.5.7. Norway
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Regulatory Framework
      • 5.5.7.3. Competitive Insights
      • 5.5.7.4. Norway Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.5.8. Denmark
      • 5.5.8.1. Key Country Dynamics
      • 5.5.8.2. Regulatory Framework
      • 5.5.8.3. Competitive Insights
      • 5.5.8.4. Denmark Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.5.9. Sweden
      • 5.5.9.1. Key Country Dynamics
      • 5.5.9.2. Regulatory Framework
      • 5.5.9.3. Competitive Insights
      • 5.5.9.4. Sweden Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Asia Pacific
    • 5.6.1. Asia Pacific Acute Repetitive Seizures Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 5.6.2. Japan
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Regulatory Framework
      • 5.6.2.3. Competitive Insights
      • 5.6.2.4. Japan Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. China
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Regulatory Framework
      • 5.6.3.3. Competitive Insights
      • 5.6.3.4. China Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. India
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Regulatory Framework
      • 5.6.4.3. Competitive Insights
      • 5.6.4.4. India Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.6.5. South Korea
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Regulatory Framework
      • 5.6.5.3. Competitive Insights
      • 5.6.5.4. South Korea Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.6.6. Australia
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Regulatory Framework
      • 5.6.6.3. Competitive Insights
      • 5.6.6.4. Australia Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.6.7. Thailand
      • 5.6.7.1. Key Country Dynamics
      • 5.6.7.2. Regulatory Framework
      • 5.6.7.3. Competitive Insights
      • 5.6.7.4. Thailand Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Latin America
    • 5.7.1. Latin America Acute Repetitive Seizures Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 5.7.2. Brazil
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Regulatory Framework
      • 5.7.2.3. Competitive Insights
      • 5.7.2.4. Brazil Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.7.3. Argentina
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Regulatory Framework
      • 5.7.3.3. Competitive Insights
      • 5.7.3.4. Argentina Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.8. MEA
    • 5.8.1. MEA Acute Repetitive Seizures Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 5.8.2. South Africa
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Regulatory Framework
      • 5.8.2.3. Competitive Insights
      • 5.8.2.4. South Africa Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.8.3. Saudi Arabia
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Regulatory Framework
      • 5.8.3.3. Competitive Insights
      • 5.8.3.4. Saudi Arabia Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.8.4. UAE
      • 5.8.4.1. Key Country Dynamics
      • 5.8.4.2. Regulatory Framework
      • 5.8.4.3. Competitive Insights
      • 5.8.4.4. UAE Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.8.5. Kuwait
      • 5.8.5.1. Key Country Dynamics
      • 5.8.5.2. Regulatory Framework
      • 5.8.5.3. Competitive Insights
      • 5.8.5.4. Kuwait Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Participant Overview
  • 6.2. Company Market Position Analysis
  • 6.3. Company Categorization
  • 6.4. Strategy Mapping
  • 6.5. Company Profiles/Listing
    • 6.5.1. UCB S.A., Belgium
      • 6.5.1.1. Overview
      • 6.5.1.2. Financial Performance
      • 6.5.1.3. Product Benchmarking
      • 6.5.1.4. Strategic Initiatives
    • 6.5.2. Neurelis, Inc.
      • 6.5.2.1. Overview
      • 6.5.2.2. Financial Performance
      • 6.5.2.3. Product Benchmarking
      • 6.5.2.4. Strategic Initiatives
    • 6.5.3. Bausch Health Companies Inc.
      • 6.5.3.1. Overview
      • 6.5.3.2. Financial Performance
      • 6.5.3.3. Product Benchmarking
      • 6.5.3.4. Strategic Initiatives
    • 6.5.4. Grupo Ferrer Internacional, S.A.
      • 6.5.4.1. Overview
      • 6.5.4.2. Financial Performance
      • 6.5.4.3. Product Benchmarking
      • 6.5.4.4. Strategic Initiatives
    • 6.5.5. SERB
      • 6.5.5.1. Overview
      • 6.5.5.2. Financial Performance
      • 6.5.5.3. Product Benchmarking
      • 6.5.5.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global acute repetitive seizures market, by region, 2018 - 2030 (USD Million)
  • Table 4. Global acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 5. North America acute repetitive seizures market, by country, 2018 - 2030 (USD Million)
  • Table 6. North America acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 7. U.S. acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 8. Canada acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 9. Mexico acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 10. Europe acute repetitive seizures market, by country, 2018 - 2030 (USD Million)
  • Table 11. Europe acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 12. UK acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 13. Germany acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 14. France acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 15. Italy acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 16. Spain acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 17. Norway acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 18. Denmark acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 19. Sweden acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 20. Asia Pacific acute repetitive seizures market, by country, 2018 - 2030 (USD Million)
  • Table 21. Asia Pacific acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 22. Japan acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 23. China acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 24. India acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 25. Australia acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 26. South Korea acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 27. Thailand acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 28. Latin America acute repetitive seizures market, by country, 2018 - 2030 (USD Million)
  • Table 29. Latin America acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 30. Brazil acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 31. Argentina acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 32. Middle East & Africa Acute repetitive seizures market, by country, 2018 - 2030 (USD Million)
  • Table 33. Middle East & Africa acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 34. South Africa acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 35. Saudi Arabia acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 36. UAE acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 37. Kuwait acute repetitive seizures market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Acute repetitive seizures market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Product outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Acute repetitive seizures market dynamics
  • Fig. 12 Acute repetitive seizures market: Porter's five forces analysis
  • Fig. 13 Acute repetitive seizures market: PESTLE analysis
  • Fig. 14 Acute repetitive seizures market: Product segment dashboard
  • Fig. 15 Acute repetitive seizures market: Product market share analysis, 2024 & 2030
  • Fig. 16 USL-261 market, 2018 - 2030 (USD Million)
  • Fig. 17 NRL-1 market, 2018 - 2030 (USD Million)
  • Fig. 18 AZ-002 market, 2018 - 2030 (USD Million)
  • Fig. 19 Diastat rectal gel market, 2018 - 2030 (USD Million)
  • Fig. 20 Others market, 2018 - 2030 (USD Million)
  • Fig. 21 Acute repetitive seizures market revenue, by region
  • Fig. 22 Regional marketplace: Key takeaways
  • Fig. 23 Regional marketplace: Key takeaways
  • Fig. 24 North America acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. country dynamics
  • Fig. 26 U.S. acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 27 Canada country dynamics
  • Fig. 28 Canada acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 29 Mexico country dynamics
  • Fig. 30 Mexico acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 31 Europe acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 32 UK country dynamics
  • Fig. 33 UK acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 34 Germany country dynamics
  • Fig. 35 Germany acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 36 France country dynamics
  • Fig. 37 France acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 38 Italy country dynamics
  • Fig. 39 Italy acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 40 Spain country dynamics
  • Fig. 41 Spain acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 42 Norway country dynamics
  • Fig. 43 Norway acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden country dynamics
  • Fig. 45 Sweden acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark country dynamics
  • Fig. 47 Denmark acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 49 Japan country dynamics
  • Fig. 50 Japan acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 51 China country dynamics
  • Fig. 52 China acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 53 India country dynamics
  • Fig. 54 India acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 55 Australia country dynamics
  • Fig. 56 Australia acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea country dynamics
  • Fig. 58 South Korea acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 59 Thailand country dynamics
  • Fig. 60 Thailand acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 61 Latin America acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 62 Brazil country dynamics
  • Fig. 63 Brazil acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 64 Argentina country dynamics
  • Fig. 65 Argentina acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 66 MEA acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 67 South Africa country dynamics
  • Fig. 68 South Africa acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 69 Saudi Arabia country dynamics
  • Fig. 70 Saudi Arabia acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 71 UAE country dynamics
  • Fig. 72 UAE acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 73 Kuwait country dynamics
  • Fig. 74 Kuwait acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 75 Company categorization
  • Fig. 76 Company market position analysis
  • Fig. 77 Strategic framework